XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Operating Activities      
Net Income $ 874 $ 1,233 $ 311
Adjustments to net income to derive net cash provided by operating activities:      
Depreciation and amortization 2,154 2,253 1,978
Share-based compensation 244 261 322
Deferred income taxes (302) (381) (240)
Change in operating assets and liabilities:      
Trade receivables, net (48) (51) (170)
Inventories (125) (149) 246
Prepaid expenses and other 81 299 (46)
Accounts payable, income taxes and other liabilities 205 (470) 867
Pension obligation 95 (123) (263)
Excess tax benefits from payments under share-based compensation plans 52 55 78
Gain on sale of Vyaire interest 0 0 (303)
Gain on sale of business 0 (336) 0
Product liability-related charges 378 914 0
Increase (Decrease) in Other Operating Assets and Liabilities, Net (68) (177) 85
Net Cash Provided by Operating Activities 3,539 3,330 2,865
Investing Activities      
Capital expenditures (810) (957) (895)
Acquisitions, net of cash acquired (164) 0 (15,155)
Proceeds from divestitures, net 0 477 534
Other, net (257) (261) (217)
Net Cash Used for Investing Activities (1,232) (741) (15,733)
Financing Activities      
Change in credit facility borrowings (485) 485 0
Proceeds from long-term debt and term loans 3,389 2,224 5,086
Payments of debt and term loans (4,664) (4,744) (3,996)
Proceeds from issuance of equity securities 2,917 0 0
Dividends paid (1,026) (984) (927)
Other, net (109) (205) (220)
Net Cash Provided by (Used for) Financing Activities 22 (3,223) (58)
Effect of exchange rate changes on cash and equivalents and restricted cash (3) (12) (17)
Net Increase (Decrease) in Cash and Equivalents and Restricted Cash 2,326 (646) (12,943)
Opening Cash and Equivalents and Restricted Cash 590 1,236 14,179
Closing Cash and Equivalents and Restricted Cash 2,917 590 1,236
Non-Cash Investing Activities      
Noncash consideration-fair value of shares issued 0 0 8,004
Noncash consideration-fair value of stock options and other equity awards $ 0 $ 0 $ 613